ANKARA, Türkiye, June 17, 2025 (GLOBE NEWSWIRE) -- EarlyHealth Group, a global pharmaceutical service provider, today announced the acquisition of Corena Ecza Deposu, Türkiye’s leading pharmaceutical distributor, strengthening its position as one of the largest service providers dedicated to the life sciences sector in Türkiye.

This acquisition supports EarlyHealth Group’s strategy to drive a $100 million portfolio of initiatives aimed at globalizing the Turkish pharmaceutical environment.

“By combining Corena’s national expertise with our international platform, we are positioned to accelerate government-led export initiatives, strengthen academic-industry collaborations, and advance Türkiye’s role in clinical research and pharmaceutical innovation,” explained Dr. Dan A. Renout, Chief Executive Officer of EarlyHealth Group.

Mrs. Nihal Aygün, Owner of Corena, stated “Our collaboration with EarlyHealth Group spans nearly two decades. This acquisition and strategic partnership reinforce our joint commitment to national priorities, specifically supporting Türkiye’s efforts to reduce pharmaceutical import dependency and positioning the country as a key contributor to the global pharmaceutical supply chain.” As part of EarlyHealth Group, Corena will spearhead these strategic initiatives across Türkiye, serving as the operational and scientific hub to advance ongoing bilateral cooperation.

The ceremonial signing took place in Dubai, United Arab Emirates, under the presence of His Excellency Onur Saylan, Consul General of the Republic of Türkiye. Distinguished guests included H.H. Sheikh Khalifa bin Khalid Al Hamed, member of the Abu Dhabi Royal Family, Her Excellency Dr. Annalee Babb, Ambassador of Barbados to the UAE, and Mr. Ahmed Emre Büyükkılıç, Country Advisor to the Investment Office of the Presidency of the Republic of Türkiye. Mr. Saylan concluded the event by stating “This partnership exemplifies the spirit of strategic cooperation between Türkiye and the United Arab Emirates. It underscores our shared commitment to advancing healthcare innovation, fostering cross-border investment, and building a platform for sustainable growth that benefits future generations.”

About EarlyHealth Group
EarlyHealth Group (EHG) is a global pharmaceutical service provider supporting clinical research and market access to the life sciences industry. Website: www.early-health.com

About Corena
Corena is a leading Turkish pharmaceutical company with over 20 years of trusted service supporting healthcare market access and distribution. Website: www.corena.com.tr

Photos accompanying this announcement are available at

https://www.globenewswire.com/NewsRoom/AttachmentNg/4b492447-f33d-4022-a555-67a19f805195

https://www.globenewswire.com/NewsRoom/AttachmentNg/e6470fea-622f-49d0-a8f5-724f4d4f82fd

For media inquiries, please contact:
EarlyHealth Group Communications
Email: press@early-health.com

This item of content is a press release from a third party provider who make no warranties or representations in connection with this content and therefore PA can make no warranties in respect of its use.

Images

Tags

More Like This

Acarpia Farmaceutici and EarlyHealth Group Expand Their Partnership to Improve Access in CARICOM and Mexico

EarlyHealth Group Acquires CYB3R, Gulf’s Fastest-Growing Cybersecurity Firm

Avania Buys Spanish MedTech CRO Anagram to Enhance Its Core CRO Offering in a New European Geography

PureHealth completes EUR 800 million acquisition of Hellenic Healthcare Group, strengthening its global platform

H.I.G. Capital Announces the Sale of Deenova S.r.l.

Ardena Signs Agreement to Expand US Footprint with the Acquisition of Advanced Drug Product Manufacturing Facility from Catalent

EVERSANA Expands Global Commercialisation Capabilities and Strengthens Agency Network with Healthware Group Acquisition

Cencora To Host Inaugural ThinkLive Cell and Gene Therapy Summit